We are live on ! Find out more
T. Rowe Price Associates

T. Rowe Price Associates Portfolio holdings

AUM $865B
1-Year Est. Return 30.76%
 

T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.

This Fund
S&P 500
This Quarter Est. Return
-6.57%
1 Year Est. Return
+30.76%
3 Year Est. Return
+117.39%
5 Year Est. Return
+143.85%
10 Year Est. Return
+1,089.89%
AUM
$992B
AUM Growth
-$120B
Cap. Flow
-$16.9B
Cap. Flow %
-1.7%
Top 10 Hldgs %
27.94%
Holding
3,085
New
108
Increased
1,637
Reduced
1,059
Closed
107

Top Buys

Rank Stock Value
1
TSLA icon
Tesla
TSLA
+$4.45B
2
JPM icon
JPMorgan Chase
JPM
+$2.22B
3
TEAM icon
Atlassian
TEAM
+$2.08B
4
NVDA icon
NVIDIA
NVDA
+$1.81B
5
AAPL icon
Apple
AAPL
+$1.67B

Sector Composition

Rank Sector Weight
1 Technology 26.79%
2 Healthcare 17.19%
3 Consumer Discretionary 15.16%
4 Financials 10.74%
5 Communication Services 10.41%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LEVI icon
2651
Levi Strauss
LEVI
$8.63B
$227K ﹤0.01%
+11,500
New +$248K
PAHC icon
2652
Phibro Animal Health
PAHC
$1.38B
$227K ﹤0.01%
11,394
+375
+3% +$7.57K
SMCI icon
2653
Super Micro Computer
SMCI
$25.3B
$227K ﹤0.01%
+59,710
New +$247K
CASS icon
2654
Cass Information Systems
CASS
$750M
$226K ﹤0.01%
+6,119
New +$244K
GDS icon
2655
GDS Holdings
GDS
$6.97B
$226K ﹤0.01%
5,758
+2
+0% +$82
GLNG icon
2656
Golar LNG
GLNG
$5.21B
$225K ﹤0.01%
+9,084
New +$150K
VBIV
2657
DELISTED
VBI Vaccines, Inc. New Common Stock (Canada)
VBIV
$225K ﹤0.01%
4,520
+565
+14% +$27.9K
PCYO icon
2658
Pure Cycle
PCYO
$273M
$224K ﹤0.01%
18,664
+500
+3% +$6.2K
IMGN
2659
DELISTED
Immunogen Inc
IMGN
$224K ﹤0.01%
46,993
+10,920
+30% +$60.5K
GNOG
2660
DELISTED
Golden Nugget Online Gaming, Inc. Class A Common Stock
GNOG
$224K ﹤0.01%
31,470
+3,572
+13% +$27.6K
AGPU
2661
Axe Compute Inc
AGPU
$96M
$223K ﹤0.01%
760
TMDX icon
2662
Transmedics
TMDX
$3.11B
$222K ﹤0.01%
8,250
-178,013
-96% -$3.19M
BRSL
2663
Brightstar Lottery PLC
BRSL
$2.15B
$221K ﹤0.01%
+8,936
New +$240K
EUCR
2664
DELISTED
Eucrates Biomedical Acquisition Corp. Ordinary Shares
EUCR
$221K ﹤0.01%
22,427
RICK icon
2665
RCI Hospitality Holdings
RICK
$230M
$220K ﹤0.01%
+3,578
New +$249K
MGNX icon
2666
MacroGenics
MGNX
$259M
$218K ﹤0.01%
24,688
+1,421
+6% +$15.7K
NKLA
2667
DELISTED
Nikola Corporation Common Stock
NKLA
$218K ﹤0.01%
677
+158
+30% +$40.3K
RMNI icon
2668
Rimini Street
RMNI
$470M
$217K ﹤0.01%
37,449
-3,919
-9% -$20.6K
SIGA icon
2669
SIGA Technologies
SIGA
$207M
$217K ﹤0.01%
30,576
+17,400
+132% +$116K
TA
2670
DELISTED
TravelCenters of America LLC
TA
$217K ﹤0.01%
5,050
+343
+7% +$14.8K
CLAR icon
2671
Clarus
CLAR
$145M
$216K ﹤0.01%
9,488
+528
+6% +$12.2K
NGVC icon
2672
Vitamin Cottage Natural Grocers
NGVC
$646M
$216K ﹤0.01%
11,009
+200
+2% +$3.31K
VAPO
2673
DELISTED
Vapotherm, Inc. Common Stock
VAPO
$216K ﹤0.01%
1,943
+723
+59% +$90.3K
RFP
2674
DELISTED
Resolute Forest Products Inc.
RFP
$216K ﹤0.01%
16,700
+200
+1% +$2.69K
BNGO icon
2675
Bionano Genomics
BNGO
$13.5M
$214K ﹤0.01%
138
+10
+8% +$13.5K

Similar funds

T. Rowe Price Associates's Q1 2022 Portfolio in Review

As of Q1 2022, T. Rowe Price Associates held 3,085 positions worth $992B, down 11% from $1.11T the previous quarter. Its ten largest holdings account for 28% of the portfolio.

T. Rowe Price Associates's Q1 2022 filing shows 108 new, 1,637 increased, 1,059 reduced and 107 closed positions. Its largest new stake was Nutrien: 6,143,560 shares worth $639M. The largest sale was Alphabet (Google) Class C, an estimated $3.24B.

By sector, the portfolio is most concentrated in Technology at 27% of assets, down from 27% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • T. Rowe Price Associates's largest Q1 2022 buy was Nutrien: 6,143,560 shares worth $639M.
  • T. Rowe Price Associates added most to Tesla in Q1 2022, an estimated $4.45B increase.
  • T. Rowe Price Associates's biggest Q1 2022 reduction was Alphabet (Google) Class C, cutting an estimated $3.24B.
  • T. Rowe Price Associates fully exited Xilinx Inc in Q1 2022, selling an estimated $481M.
  • T. Rowe Price Associates's ten largest holdings make up 28% of its $992B portfolio in Q1 2022.
  • T. Rowe Price Associates opened 108 new positions and closed 107 in Q1 2022.
  • T. Rowe Price Associates's portfolio value fell 11% quarter-over-quarter to $992B.

Based on T. Rowe Price Associates's 13F filing for Q1 2022, filed 16 May 2022.